Courage and Innovation Symposium
Thank You to Everyone Who Joined Us at the 2025 Symposium.
2026 Date Coming Soon!
Courage and Innovation Symposium
Thank You to Everyone Who Joined Us at the 2025 Symposium.
2026 Date Coming Soon!
Join us for the 8th Annual Courage and Innovation Symposium!
2026 CIS Date Coming Soon!
program Directors
Bow (Ben) Chung, MD
Christopher T. Salerno, MD, FACS, FACC
Christopher T. Salerno, MD, FACS, FACC
Co-Course Director
Assistant Professor of Medicine
University of Chicago Medicine
Chicago, IL
Christopher T. Salerno, MD, FACS, FACC
Christopher T. Salerno, MD, FACS, FACC
Christopher T. Salerno, MD, FACS, FACC
Co-Course Director
Professor of Surgery
Chief, Section of Cardiac Surgery
Co-Director, Heart and Vascular Center
Surgical Director, Heart Transplant and Mechanical Assist Device Program
University of Chicago Medicine
Chicago, IL
COURSE OVERVIEW
The 2026 Courage and Innovation Symposium is a one-day activity structured as a comprehensive educational symposium striving to educate clinicians, physician trainees, advanced practitioners, nurses, and other healthcare professionals across a wide range of specialties in the application of innovative therapies for cardiovascular disease.
The distinguished faculty for this event includes many of the foremost clinicians at the University of Chicago Heart and Vascular Center as well as internationally recognized guest faculty. Through focused didactics, panel discussion, case studies and interactive dialogue, participants will gain both broad perspective and detailed insights into medical and surgical therapies for complex cardiovascular disease.
About Courage and Innovation
TARGET AUDIENCE
The 2026 Courage and Innovation Symposium has been designed to meet the educational requirements for clinicians, physician trainees, nurses, and other healthcare professionals across a wide range of specialties in the application of innovative therapies for cardiovascular disease.
SYMPOSIUM OBJECTIVES
Upon Completion of this CME activity participants should be able to:
- Identify advanced heart failure and contemporary therapeutic management.
- Identify the current diagnostic and management strategies for the common and uncommon cardiomyopathies, including infiltrative cardiomyopathy.
- Discuss common cardiac conduction abnormalities in heart failure and therapeutics.
- Discuss the latest scientific evidence and guidelines in cardiogenic shock management and the role for acute mechanical circulatory support.
- Discuss the latest evidence for contemporary management of pulmonary hypertension
- Evaluate the role of molecular monitoring for rejection in cardiac transplantation
- State current practice strategies of advanced practice providers in the care of heart failure and heart transplant patients.
